Grant: Discovery Grants Program - Individual
University of Western Ontario
$22,140.00
Syntheis and biofunctionalization of degradable ester-amide biomaterials for tissue engineering applications
FY 2008-09
Summary
THE NATURE OF THE WORK TO BE DONE: Tissue engineering holds great promise as an alternative strategy to current treatment modalities of diseased or otherwise failed tissues. Most strategies of tissue engineering rely on porous 3-dimensional scaffolds as templates to guide tissue regeneration. These scaffolds play the role of a synthetic extracellular matrix that facilitates the organization of cells into a 3-dimensional architecture and address the mechanical stimuli that rule the growth and formation of the desired tissue. The work proposed here involves the design of novel scaffolding materials from naturally occurring amino acids.
WHY AND TO WHOM THE RESEARCH IS IMPORTANT: Every year nearly 23,000 Canadians undergo coronary artery bypass surgeries. With the rapid growth of the elderly segment of the population, the number of coronary artery interventions is expected to increase dramatically. Although prosthetic vascular grafts are still in wide clinical use, such grafts often do not fit well and do not respond appropriately to physiological conditions in the native tissue they replaced. Patient-specific tissue-engineered blood vessels will eliminate the need of drugs since the tissue will not be rejected. This reduces the impact of the surgical procedure and improves quality of life to patients. To achieve all these, scaffolding material design is at the heart of tissue engineering research.
HOW CANADA WILL BENEFIT: Tissue engineering is a new and vibrant area of research with great potential to revolutionize current treatment modalities. Thus the design of novel scaffolding materials is a significant benefit to Canada to play a leading role in this area.
THE ANTICIPATED OUTCOMES: Tissue engineering strategies rely on the choice of appropriate biomaterials that will act as a temporary support for the cells. Since scaffold-guided tissue engineering is by far the most plausible strategy, the design of novel and new classes of biodegradable biomaterials with biological recognition capability could provide key information to advance in this promising field of research.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
288130-2008
Name nom
Mequanint, Kibret
Department département
Chemical and Biochemical Engineering
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
22140
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
5
Application title
Syntheis and biofunctionalization of degradable ester-amide biomaterials for tissue engineering applications
Keyword
NA
Application summary
THE NATURE OF THE WORK TO BE DONE: Tissue engineering holds great promise as an alternative strategy to current treatment modalities of diseased or otherwise failed tissues. Most strategies of tissue engineering rely on porous 3-dimensional scaffolds as templates to guide tissue regeneration. These scaffolds play the role of a synthetic extracellular matrix that facilitates the organization of cells into a 3-dimensional architecture and address the mechanical stimuli that rule the growth and formation of the desired tissue. The work proposed here involves the design of novel scaffolding materials from naturally occurring amino acids.
WHY AND TO WHOM THE RESEARCH IS IMPORTANT: Every year nearly 23,000 Canadians undergo coronary artery bypass surgeries. With the rapid growth of the elderly segment of the population, the number of coronary artery interventions is expected to increase dramatically. Although prosthetic vascular grafts are still in wide clinical use, such grafts often do not fit well and do not respond appropriately to physiological conditions in the native tissue they replaced. Patient-specific tissue-engineered blood vessels will eliminate the need of drugs since the tissue will not be rejected. This reduces the impact of the surgical procedure and improves quality of life to patients. To achieve all these, scaffolding material design is at the heart of tissue engineering research.
HOW CANADA WILL BENEFIT: Tissue engineering is a new and vibrant area of research with great potential to revolutionize current treatment modalities. Thus the design of novel scaffolding materials is a significant benefit to Canada to play a leading role in this area.
THE ANTICIPATED OUTCOMES: Tissue engineering strategies rely on the choice of appropriate biomaterials that will act as a temporary support for the cells. Since scaffold-guided tissue engineering is by far the most plausible strategy, the design of novel and new classes of biodegradable biomaterials with biological recognition capability could provide key information to advance in this promising field of research.